Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Schizophrenia

The importance of evidence in clinical practice

    • Congress Reports
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • 3 minute read

Every practitioner strives to provide the best possible treatment to their patients. The optimal goal would be to cure the disease if possible, or at least to stop it without inducing side effects. Evidence-based recommendations are readily used to assess different therapeutic regimens. But what does evidence mean anyway – especially in everyday clinical practice?

The buzzword “evidence” conveys a certain degree of confidence in medicine. Recommendations made on this basis are not based solely on theories or expert opinion, but on scientific evidence. The aim is to generate reliable answers regarding optimal treatment management in the respective indication. Accordingly, the evidence pyramid was used early on to categorize the different sources (Fig. 1) [1]. Different versions of the evidence pyramid have been described. But all focused on using weaker study designs as a base (basic science and case series), followed by case-control and cohort studies in the middle, then randomized controlled trials (RCTs), and systematic reviews and meta-analyses at the top. In principle, this may well be correct. Nevertheless, even clinical studies are not free of errors. Typical biases are, for example, in execution, evaluation, or reporting. However, patient selection, treatment plan, and treatment setting may also determine the extent to which study results can be generalized.

 

 

There is always a debate about how valid data from clinical trials can actually be. A recent review showed that of 1640 studies analyzed that provided information on bias risk, 1013 (62%) were associated with high bias risk (poor), 494 (30%) were unclear, and only 133 (8%) were associated with low bias risk [2]. Back in 1994, Doug Altman opined, “We need less research, better research, and research that is done for the right reasons.” But what does that mean in terms of implementation?

Evidence does not necessarily mean well studied

Taking studies in the field of schizophrenia, for example, a meta-analysis regarding the efficacy of long-acting injectable (LAI) vs. oral antipsychotics with respect to relapse prevention in maintenance therapy showed that there were no significant differences [3]. At least not when analyzing randomized clinical trials (RCTs). If, on the other hand, cohort studies and pre-post studies are also included in the analysis, a significant superiority of LAI over oral administration is shown [4]. However, what has also been underlined is the fact that patients in randomized clinical trials are usually very adherent and do not always match the clients in everyday treatment [3].

Are real-world studies the better evidence base?

Real-world evidence (RWE) is therefore becoming increasingly important. It corresponds to clinical evidence regarding the benefits, advantages, and risks of a drug obtained via real-world data (RWD). These are often generated via registry studies, non-interventional studies, case reports, and practice experience reports. The advantage of RWD: the real patient population is represented. Many patients with comorbidities and comedications are not enrolled in clinical trials, even though they may play a significant role in clinical practice. Therefore, the results are not necessarily directly transferable to everyday care. RWE closes this gap. Real-world studies are therefore becoming increasingly important and are also being carried out more frequently. Currently, a 13-week non-interventional, prospective, multicenter study (ACTIVATE) is being acquired to evaluate the efficacy and tolerability profile of brexpiprazole in adult schizophrenia patients to be treated as outpatients. The aim is to use the newly gained knowledge to make treatment management more patient-centered – taking into account the reality of life in Switzerland.

Congress: FomF Update Refresher
 

Literature:

  1. Murad, et al: New evidence pyramid. Evid Based Med 2016; 21: 125-127.
  2. Pirosca, et al: Tolerating bad health research: the continuing scandal. Trials 2022; 23: 458.
  3. Kishimoto, et al: Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: A meta-analysis of randomized trials. Schizophrenia Bulletin 2014; 192-213.
  4. Kishimoto, et al: Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort and pre-post studies. Lancet Psychiatry 2021; 8(5): 387-404.

 

InFo NEUROLOGY & PSYCHIATRY 2022; 20(5): 24.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Evidence
  • fomf
  • Schizophrenia
Previous Article
  • Case series

Topical therapy of scalp psoriasis

  • Cases
  • Dermatology and venereology
  • Education
  • RX
  • Studies
View Post
Next Article
  • Undesirable pigments

Tattoo removal

  • CME continuing education
  • Dermatology and venereology
  • Education
  • RX
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.